Shu Ning

ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Venues

Molecular cancer therapeutics

Clinical cancer research : an official journal of the American Association for Cancer Research

University of California Davis

Imperial College London (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of California Davis Sep 23o 2018

United States

Graduate Researcher :: Urologic Surgery

Education History

Imperial College London

United Kingdom

MSC

Publications

Alan P Lombard, Cameron M Armstrong, Leandro S D'Abronzo, Shu Ning, Amy R Leslie, Masuda Sharifi, Wei Lou, Christopher P Evans, Marc Dall'Era, Hong-Wu Chen, Xinbin Chen, Allen C Gao
Olaparib-Induced Senescence Is Bypassed through G2-M Checkpoint Override in Olaparib-Resistant Prostate Cancer. Molecular cancer therapeutics 21 (4) (2022)
Shu Ning, Chengfei Liu, Wei Lou, Joy C Yang, Alan P Lombard, Leandro S D'Abronzo, Neelu Batra, Ai-Ming Yu, Amy R Leslie, Masuda Sharifi, Christopher P Evans, Allen C Gao
Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide Treatment. Molecular cancer therapeutics 21 (10) (2022)
Alan P Lombard, Wei Lou, Cameron M Armstrong, Leandro S D'Abronzo, Shu Ning, Christopher P Evans, Allen C Gao
Activation of the ABCB1 Amplicon in Docetaxel- and Cabazitaxel-Resistant Prostate Cancer Cells. Molecular cancer therapeutics 20 (10) (2021)
Cameron M Armstrong, Chengfei Liu, Liangren Liu, Joy C Yang, Wei Lou, Ruining Zhao, Shu Ning, Alan P Lombard, Jinge Zhao, Leandro S D'Abronzo, Christopher P Evans, Pui-Kai Li, Allen C Gao
Steroid Sulfatase Stimulates Intracrine Androgen Synthesis and is a Therapeutic Target for Advanced Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (22) (2020)
Jinge Zhao, Shu Ning, Wei Lou, Joy C Yang, Cameron M Armstrong, Alan P Lombard, Leandro S D'Abronzo, Christopher P Evans, Allen C Gao, Chengfei Liu
Cross-Resistance Among Next-Generation Antiandrogen Drugs Through the AKR1C3/AR-V7 Axis in Advanced Prostate Cancer. Molecular cancer therapeutics 19 (8) (2020)

Shu Ning.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shu Ning